Literature DB >> 34089100

[Organ preservation after short-course radiotherapy and transanal endoscopic microsurgery for early-stage rectal cancer (TREC)].

Julius Pochhammer1, Jürgen Dunst2.   

Abstract

Entities:  

Year:  2021        PMID： 34089100     DOI： 10.1007/s00066-021-01795-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Impact of radiotherapy on anorectal function in patients with rectal cancer following a watch and wait programme.

Authors:  Marit E van der Sande; Britt J P Hupkens; Maaike Berbée; Sander M J van Kuijk; Monique Maas; Jarno Melenhorst; Geerard L Beets; Stéphanie O Breukink
Journal:  Radiother Oncol       Date:  2018-12-21       Impact factor: 6.280

2.  Quality of life after rectal-preserving treatment of rectal cancer.

Authors:  Helen J S Jones; Issam Al-Najami; Chris Cunningham
Journal:  Eur J Surg Oncol       Date:  2020-07-22       Impact factor: 4.424

3.  Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study.

Authors:  Anouk J M Rombouts; Issam Al-Najami; Natalie L Abbott; Ane Appelt; Gunnar Baatrup; Simon Bach; Aneel Bhangu; Karen-Lise Garm Spindler; Richard Gray; Kelly Handley; Manjinder Kaur; Ellen Kerkhof; Camilla Jensenius Kronborg; Laura Magill; Corrie A M Marijnen; Iris D Nagtegaal; Lars Nyvang; Femke P Peters; Per Pfeiffer; Cornelis Punt; Philip Quirke; David Sebag-Montefiore; Mark Teo; Nick West; Johannes H W de Wilt
Journal:  BMJ Open       Date:  2017-12-28       Impact factor: 2.692

4.  Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.

Authors:  J Joshua Smith; Oliver S Chow; Marc J Gollub; Garrett M Nash; Larissa K Temple; Martin R Weiser; José G Guillem; Philip B Paty; Karin Avila; Julio Garcia-Aguilar
Journal:  BMC Cancer       Date:  2015-10-23       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.